Marc Belsky
2018 - Five Prime Therapeutics
Compensation breakdown
| Option Awards | $214,697 |
|---|---|
| Salary | $138,260 |
| Stock Awards | $56,070 |
| Other | $6,000 |
| Total | $415,027 |
Belsky received $214.7K in option awards, accounting for 52% of the total pay in 2018.
Belsky also received $138.3K in salary, $56.1K in stock awards and $6K in other compensation.
Rankings
In 2018, Marc Belsky's compensation ranked 12,434th out of 14,244 executives tracked by ExecPay. In other words, Belsky earned more than 12.7% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 12,434 out of 14,244 | 13th |
Division Manufacturing | 5,036 out of 5,765 | 13th |
Major group Chemicals And Allied Products | 1,911 out of 2,128 | 10th |
Industry group Drugs | 1,636 out of 1,817 | 10th |
Industry Pharmaceutical Preparations | 1,253 out of 1,391 | 10th |
Pay ratio
| Marc Belsky's Pay | $415,027 |
|---|---|
| Median Employee's Pay | $201,670 |
| Pay Ratio | 2to 1 |
In 2018, the annual total compensation of Marc Belsky was $415,027.
The annual total compensation of the median employee at Five Prime Therapeutics was $201,670.
The ratio of Marc Belsky's pay to the pay of median employee was therefore 2 to one.
Belsky's colleagues
We found six more compensation records of executives who worked with Marc Belsky at Five Prime Therapeutics in 2018.
2018
Aron Knickerbocker
Five Prime Therapeutics
Chief Executive Officer
2018
David Smith
Five Prime Therapeutics
Chief Financial Officer
2018
Bryan Irving
Five Prime Therapeutics
Chief Scientific Officer
2018
Helen Collins
Five Prime Therapeutics
Chief Medical Officer
2018
Francis Sarena
Five Prime Therapeutics
Secretary
2018
Linda Rubinstein
Five Prime Therapeutics